Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Tofacitinib treatment for hair loss may worsen acne.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Hataedock treatment improved skin health and reduced atopic dermatitis symptoms by enhancing the skin barrier and reducing inflammation.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Tofacitinib may help regrow hair in alopecia areata patients.

Baricitinib effectively regrew hair in a woman with alopecia universalis after other treatments failed.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.